Display options
Cite
Jiao X, Tian L, Zhang Z, et al. . Cancers (Basel). 2021;13(9)doi: 10.3390/cancers13092171.
Jiao, X., Tian, L., Zhang, Z., Balcerek, J., Kossenkov, A. V., Casimiro, M. C., Wang, C., Liu, Y., Ertel, A., Soccio, R. E., Chen, E. R., Liu, Q., Ashton, A. W., Tong, W., & Pestell, R. G. (2021). . Cancers, 13(9), . https://doi.org/10.3390/cancers13092171
Jiao, Xuanmao, et al. "." Cancers vol. 13,9 (2021). doi: https://doi.org/10.3390/cancers13092171
Jiao X, Tian L, Zhang Z, Balcerek J, Kossenkov AV, Casimiro MC, Wang C, Liu Y, Ertel A, Soccio RE, Chen ER, Liu Q, Ashton AW, Tong W, Pestell RG. . Cancers (Basel). 2021 Apr 30;13(9). doi: 10.3390/cancers13092171. PMID: 33946495; PMCID: PMC8125290.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2021 Apr 30;13(9). doi: 10.3390/cancers13092171.

[No title available]

Cancers

Xuanmao Jiao, Lifeng Tian, Zhao Zhang, Joanna Balcerek, Andrew V Kossenkov, Mathew C Casimiro, Chenguang Wang, Yichuan Liu, Adam Ertel, Raymond E Soccio, Eric R Chen, Qin Liu, Anthony W Ashton, Wei Tong, Richard G Pestell

Affiliations

  1. Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Wynnewood, PA 19096, USA.
  2. Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  3. Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA.
  4. Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, PA 19107, USA.
  5. Department of Science and Mathematics, Abraham Baldwin Agricultural College, Tifton, GA 31794, USA.
  6. Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19146, USA.
  7. Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  8. Lankenau Institute for Medical Research, Wynnewood, PA 19069, USA.

PMID: 33946495 PMCID: PMC8125290 DOI: 10.3390/cancers13092171

Abstract

HER2, which is associated with clinically aggressive disease, is overexpressed in 15-20% of breast cancers (BC). The host immune system participates in the therapeutic response of HER2

Keywords: breast cancer; lipogenesis; peroxisome proliferator-activated receptor gamma (PPARĪ³), nuclear receptor

References

  1. Cancer Res. 2014 Dec 1;74(23):7103-14 - PubMed
  2. Oncotarget. 2014 Sep 15;5(17):7303-15 - PubMed
  3. Immunity. 2014 Jul 17;41(1):49-61 - PubMed
  4. Chem Rev. 2011 Oct 12;111(10):6321-40 - PubMed
  5. Cancer Res. 2014 Jan 15;74(2):508-19 - PubMed
  6. Science. 2014 May 23;344(6186):921-5 - PubMed
  7. Br J Pharmacol. 2004 Dec;143(8):933-7 - PubMed
  8. Cancers (Basel). 2019 Nov 20;11(12): - PubMed
  9. Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19035-9 - PubMed
  10. Nat Immunol. 2014 Nov;15(11):1026-37 - PubMed
  11. Cancer Med. 2016 Nov;5(11):3246-3259 - PubMed
  12. Clin Exp Metastasis. 2015 Jan;32(1):65-72 - PubMed
  13. Int J Cancer. 2007 Feb 1;120(3):702-13 - PubMed
  14. Int J Mol Sci. 2018 Jul 24;19(8): - PubMed
  15. Science. 1987 Jan 9;235(4785):177-82 - PubMed
  16. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  17. Nat Commun. 2018 Sep 25;9(1):3915 - PubMed
  18. Front Immunol. 2018 May 08;9:893 - PubMed
  19. Sensors (Basel). 2017 Nov 13;17(11): - PubMed
  20. Cancer Res. 1999 Nov 15;59(22):5671-3 - PubMed
  21. Cancer Res. 2012 Aug 1;72(15):3839-50 - PubMed
  22. Nat Immunol. 2014 Aug;15(8):717-26 - PubMed
  23. Breast Cancer Res. 2014 Jul 24;16(4):411 - PubMed
  24. Nucl Med Biol. 2006 Oct;33(7):847-54 - PubMed
  25. Mol Cell. 1999 Jun;3(6):799-804 - PubMed
  26. Cancer Res. 2009 Dec 15;69(24):9236-44 - PubMed
  27. Genome Res. 2012 Sep;22(9):1813-31 - PubMed
  28. Nat Rev Drug Discov. 2018 Dec;17(12):887-904 - PubMed
  29. Genome Biol. 2014;15(12):550 - PubMed
  30. Genes Dev. 2008 Nov 1;22(21):2941-52 - PubMed
  31. J Biol Chem. 2012 Sep 7;287(37):31116-25 - PubMed
  32. BMC Genomics. 2011 Mar 16;12:152 - PubMed
  33. Ann Oncol. 2018 Jan 1;29(1):170-177 - PubMed
  34. J Biol Chem. 2002 May 31;277(22):19649-57 - PubMed
  35. Nat Rev Clin Oncol. 2017 Jan;14(1):11-31 - PubMed
  36. Cold Spring Harb Perspect Biol. 2014 Apr 01;6(4):a020768 - PubMed
  37. Mol Cell Biol. 2002 Apr;22(8):2607-19 - PubMed
  38. Cancer Res. 2010 Jul 15;70(14):5728-39 - PubMed
  39. Mol Cancer Res. 2011 Nov;9(11):1449-61 - PubMed
  40. J Clin Invest. 2000 Feb;105(3):287-92 - PubMed
  41. Genes Dev. 2017 May 15;31(10):1007-1023 - PubMed
  42. Cancer Res. 2010 Feb 1;70(3):1141-53 - PubMed
  43. Oncogene. 2014 Apr 24;33(17):2179-90 - PubMed
  44. J Immunother Cancer. 2019 Mar 29;7(1):90 - PubMed
  45. Am J Pathol. 2004 Nov;165(5):1743-53 - PubMed
  46. Cell. 2010 May 14;141(4):668-81 - PubMed
  47. Med Phys. 2016 Oct;43(10):5380 - PubMed
  48. Am J Pathol. 2006 Nov;169(5):1784-801 - PubMed
  49. Lancet Oncol. 2017 Jan;18(1):52-62 - PubMed
  50. Nat Rev Immunol. 2010 May;10(5):365-76 - PubMed
  51. Nat Med. 1998 Sep;4(9):1058-61 - PubMed
  52. Nat Med. 2013 Oct;19(10):1264-72 - PubMed
  53. Cancer Res. 2006 Sep 1;66(17):8529-41 - PubMed
  54. Lancet Oncol. 2017 Dec;18(12):1688-1700 - PubMed
  55. Ann N Y Acad Sci. 2020 May 22;: - PubMed
  56. J Biol Chem. 1999 Mar 19;274(12):7913-22 - PubMed
  57. Nat Commun. 2018 Jan 2;9(1):21 - PubMed
  58. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6102-6 - PubMed
  59. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2491-6 - PubMed
  60. Genesis. 2007 Sep;45(9):593-605 - PubMed
  61. Mol Cell. 1998 Feb;1(3):465-70 - PubMed
  62. J Cell Sci. 2010 Oct 1;123(Pt 19):3389-400 - PubMed
  63. J Clin Oncol. 2015 Mar 1;33(7):701-8 - PubMed
  64. J Clin Invest. 2005 Dec;115(12):3484-93 - PubMed
  65. Cell. 2017 Oct 19;171(3):683-695.e18 - PubMed
  66. Oncotarget. 2012 Mar;3(3):345-56 - PubMed
  67. BMC Bioinformatics. 2011 Aug 04;12:323 - PubMed
  68. Cancer Res. 2019 Oct 1;79(19):4801-4807 - PubMed
  69. Cell. 1994 Dec 30;79(7):1147-56 - PubMed
  70. Cancer Cell. 2019 Jun 10;35(6):885-900.e10 - PubMed
  71. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13771-6 - PubMed
  72. Cell Death Dis. 2012 Aug 09;3:e361 - PubMed
  73. Genome Biol. 2008;9(9):R137 - PubMed
  74. Lancet Oncol. 2018 Jan;19(1):40-50 - PubMed
  75. Nat Methods. 2012 Mar 04;9(4):357-9 - PubMed
  76. Nat Med. 1998 Sep;4(9):1053-7 - PubMed
  77. J Natl Cancer Inst. 2000 Mar 1;92(5):418-23 - PubMed
  78. Cancer Cell. 2019 Apr 15;35(4):588-602.e10 - PubMed
  79. Cancer Res. 2003 Jun 15;63(12):3395-402 - PubMed
  80. Cancer Res. 2006 Oct 15;66(20):9986-94 - PubMed
  81. Curr Biol. 2020 Mar 23;30(6):R246-R248 - PubMed
  82. Breast Cancer Res. 2021 Jan 23;23(1):11 - PubMed
  83. N Engl J Med. 2006 Dec 28;355(26):2733-43 - PubMed
  84. Dev Cell. 2011 Feb 15;20(2):256-63 - PubMed
  85. Cancers (Basel). 2020 Jan 20;12(1): - PubMed
  86. Cancer Cell. 2018 Jan 8;33(1):60-74.e6 - PubMed
  87. Biochemistry. 2002 May 28;41(21):6640-50 - PubMed
  88. J Clin Invest. 2008 Jan;118(1):64-78 - PubMed
  89. N Engl J Med. 2015 Feb 19;372(8):724-34 - PubMed
  90. Proc Natl Acad Sci U S A. 2017 May 16;114(20):E3954-E3963 - PubMed
  91. Cancer Discov. 2015 Jan;5(1):22-4 - PubMed
  92. N Engl J Med. 2012 Nov 8;367(19):1783-91 - PubMed
  93. J Cell Biol. 2013 Apr 29;201(3):467-84 - PubMed
  94. Mol Cell Biol. 2013 Aug;33(16):3354-64 - PubMed
  95. Int J Biochem Cell Biol. 2009 Nov;41(11):2334-42 - PubMed
  96. Proc Natl Acad Sci U S A. 2007 May 1;104(18):7438-43 - PubMed
  97. Cell Stem Cell. 2013 Jul 3;13(1):102-16 - PubMed
  98. Genes Dev. 2004 Mar 1;18(5):528-40 - PubMed
  99. Cell Adh Migr. 2014;8(4):294-307 - PubMed
  100. Nat Rev Cancer. 2007 May;7(5):389-97 - PubMed
  101. Signal Transduct Target Ther. 2017;2: - PubMed
  102. Mol Cell Biol. 2000 Jan;20(2):672-83 - PubMed
  103. Breast Cancer Res Treat. 2008 Dec;112(3):437-51 - PubMed
  104. J Clin Invest. 2012 Mar;122(3):833-43 - PubMed
  105. Proc Natl Acad Sci U S A. 2014 May 27;111(21):7771-6 - PubMed
  106. Nat Commun. 2019 Jul 1;10(1):2901 - PubMed
  107. Cancer Treat Rev. 2018 Jun;67:10-20 - PubMed
  108. Nature. 2016 Dec 22;540(7634):588-592 - PubMed

Publication Types

Grant support